JLABS | Reducing vein-to-vein time for cell therapy

JLABS | Reducing vein-to-vein time for cell therapy

This Johnson & Johnson–hosted event explores how automation and real-time analytics can speed up the vein-to-vein timeline in CAR-T therapy, with experts sharing advances in manufacturing, quality control, and scalability. The session takes place in Utrecht and is also available online, with the option to combine attendance with the Oncode Accelerator Summit.

Hosted by Johnson & Johnson, this event explores how automation and real-time analytics can shorten the vein-to-vein timeline in CAR-T cell therapy—enhancing access, reducing costs, and improving patient outcomes.

Speakers from Johnson & Johnson, NecstGen, Cellular Origins, SymCel, and NanoCell Tx will share innovations aimed at streamlining manufacturing, quality control, and scalability in cell and gene therapy.

The session will be held in Utrecht (venue to be confirmed) and can also be attended virtually. Participation can be combined with the Oncode Accelerator Summit at Jaarbeurs Utrecht in the afternoon.

Register here

Testimonials

testimonial

The software course has provided invaluable information as our TTO expands to take on software cases.

Tom Withnell

University of Vienna, Austria

testimonial

ASTP Annual conference is a unique opportunity to take time to exchange best practices among TT professionals and to network at an EU level.

Cécile Cavalade

ULB TTO, Belgium

testimonial

This course offers an opportunity to meet likeminded people, share tips and tricks, and dive into different approaches to help you set up and improve KTO processes.

Brechtje Vreenegoor

Radboud University, Netherlands

testimonial

Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.

Bruno Woeran

Merinova OY - TII President, Finland

testimonial

I really like the course and the networking. I would like to come again.

Nancy Goel

Qatar Foundation, Qatar